Intel
INTC
Micron Technology
MU
Oracle
ORCL
Alibaba
BABA
Advanced Micro Devices
AMD
US Stock MarketDetailed Quotes
TLX Telix Pharmaceuticals
- 17.900
- +0.710+4.13%
Trading Feb 18 10:20 ET
5.99BMarket Cap201.12P/E (TTM)
18.769High17.530Low2.65KVolume17.530Open17.190Pre Close47.51KTurnover0.02%Turnover Ratio1988.87P/E (Static)334.72MShares19.99052wk High23.34P/B304.30MFloat Cap14.01052wk Low--Dividend TTM17.00MShs Float19.990Historical High--Div YieldTTM7.21%Amplitude14.010Historical Low17.941Avg Price1Lot Size
Trending Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Telix Pharmaceuticals Stock Forum
Clinical Trial Success: Telix's Revolutionary Prostate Cancer Treatment Shows Promising Results
Inside Telix's Strategic $45M ImaginAb Acquisition: Next-Gen Cancer Treatment Pipeline Secured
Telix to Acquire Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform
Positive
Strategic acquisition of next-generation therapeutic pipeline and technology platform
Access to state-of-the-art California research facility and expert team
Enhanced in-house capabilities in antibody engineering
Technology enables highly specific cancer targeting with improved efficiency
Potential for expansion into new therapy areas
Negative
Significant upf...
No comment yet